mechanism through which rare genetic variation may lead to or protecting from excessive body weight gain Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

the experiment designed to kill receptor signaling that instead amplified it, the tethered agonist model specific function - Adhesion GPCRs: self cleaving receptors, huge N termini, and the tethered agonist model That inversion became the basis for the model his lab proposed in 2011, in which removing or reconfiguring orphan and adhesion GPCRs - 34:00 The truncation that was supposed to kill signaling - 37:34 Pulling the pin from the grenade: the tethered agonist model - 39:38 Are adhesion GPCRs druggable, and what GPR97 changed

Real-world case studies and data-driven models for pipeline prioritization, resource allocation, and Find the right collaboration model for your program.

Why receptor localization and scaffolding dramatically shift functional readouts in disease models. validation under real experimental constraints, Tried to map signaling heterogeneity in disease-relevant models

much as a confirmation - if you look in the right system, receptors show you things overexpression models SCIENTIFIC THEMES OF THE CONVERSATION The native cell argument - why overexpression models produce systematically you screen in determines the biology you can find Running a GPCR screen in a HEK cell overexpression model direct product of that discipline - a result that would have been invisible in a standard overexpression model had already won their Nobel Prize 12:39 Co-founding CUE Biotech and Caden Biosciences - allosteric modulator

My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since

My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since

He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled

transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models

His research group uses a combination of pharmacological investigations and mathematical modeling to

list Strategic Partner(s) How Lipid Rafts Organize GPCR Signaling Scientific Abstract The classical model Sedaghat cautions that extrapolating from these models requires care, because every prediction still

Overall, the lab works on diverse models and diseases, and has developed a wide array of tools to dissect

the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models

computational structural biology tools and rational drug design approaches, ranging from molecular modeling

the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fibrosis in acute and chronic mouse models A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and

Seeing that a drug could carry more than one efficacy, he says, shattered a model he had felt secure He is unusually plain about what this felt like: not the relief of finally seeing, but the recognition be cleanly separated in a simple assay and then meet an in vivo environment that adds nuances nobody modeled

Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain (biochemistry, cell biology, genetics) and experimental systems (purified proteins, cultured cells, model Garcia-Marcos's academic journey, which spans training in Spain, Belgium, and a postdoctoral fellowship

There she focused on the different modes of action of Adhesion GPCRs and found that they do not only different signals on a molecular level and how these are translated into physiological functions in various model

Premium members get the complete intelligence. iPSC-Derived GPCR Models — Terry Hébert Live April 16

Sam Hoare brings a data analyst's perspective to GPCR pharmacology — one trained in allosteric modulation After a PhD on allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics, and pharmacological modeling The underlying pharmacological theory, from operational models of agonism to allosteric binding equations Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors

Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects

The result was a structured group management model built around four specialized subgroups, each with 15 - subgroups, leadership training, and delegation 40:41 What excites Gloriam today - open science models

By suppressing glutamate release across circuits in the basal ganglia, mGlu2 is positioned to modulate this receptor from the bench to the behaving animal, using optogenetics and circuit-selective mouse models Her lab investigates how GPCRs modulate synaptic transmission in brain circuits involved in reinforcement It is also a complication: a receptor that modulates so many circuits will inevitably produce wanted modulomics - studying circuit-specific GPCR function in the basal ganglia 20:45 Operant behavioral models

. 🌟 By teaching with us, you gain: ✔ Premium Membership for you and your team for one year (no credit Course details – title, format (short talk / mini-course / series), audience, main objectives, expected after submission). 🧱 Step 2: Plan Your Course Structure Decide how your course will flow — number of modules

His research established the beta-2 adrenergic receptor as the primary model system for understanding Beta-adrenergic receptors as a model system — Why the adrenergic system, with its rich pharmacological

Listeners will gain insight into the scientific reasoning behind GPCR structural studies, the evolving New Tools Enable Re-exploring Old Questions Advances in cryo-EM, computational modeling, and machine That unusual binding mode might explain why it has been so difficult to identify small-molecule ligands Yamina Berchiche: Unless you start thinking about allosteric modulators. Dr. Joseph Kim: Right—and once you start thinking about allosteric modulation, you open an entirely new set

masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model

validation in GPCR assay design Building reagents that must work in complex tissues, not just simplified models chemistry from the University of Bari in 2018, including research training at the CIQUS Research Center in Spain Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through

The same approach distinguishes what an allosteric modulator does to affinity versus efficacy, including masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model

Marsha Pierce | Midewestern University October 29, 2026 Translational Pharmacology & Disease Models Details You're engaging directly with the expert — not submitting a question to a moderator. Each session begins with a focused presentation from the guest expert, followed by moderated discussion